Cargando…

Implication of IL-17 in Bone Loss and Structural Damage in Inflammatory Rheumatic Diseases

Proinflammatory cytokines play an important role in the systemic and focal bone loss associated with chronic inflammatory diseases. Targeting these cytokines with biologics and small molecules has led to a major improvement of the bone health of patients with inflammatory arthritis. Cytokines from t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Le Goff, Benoit, Bouvard, Béatrice, Lequerre, Thierry, Lespessailles, Eric, Marotte, Hubert, Pers, Yves-Marie, Cortet, Bernard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710740/ https://www.ncbi.nlm.nih.gov/pubmed/31485194 http://dx.doi.org/10.1155/2019/8659302

Ejemplares similares

Novel insights into the anatomy and histopathology of the sacroiliac joint and correlations with imaging signs of sacroiliitis in case of axial spondyloarthritis
por: Prati, Clément, et al.
Publicado: (2023)

Immunomodulation with IL-17 and TNF-α in spondyloarthritis: focus on the eye and the central nervous system
por: How Shing Koy, Elsa, et al.
Publicado: (2021)

Role of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview
por: Schinocca, Claudia, et al.
Publicado: (2021)

Mesenchymal Stromal Cells: Updates and Therapeutic Outlook in Rheumatic Diseases
por: Pers, Yves-Marie, et al.
Publicado: (2013)

Serum Levels of IL-17 and IL-23 in Patients With Rheumatic Mitral Stenosis
por: Bilik, Mehmet Zihni, et al.
Publicado: (2016)

Variations in the metabolome in response to disease activity of rheumatoid arthritis
por: Tatar, Zuzana, et al.
Publicado: (2016)

Inhibiting IL-17A and IL-17F in Rheumatic Disease: Therapeutics Help to Elucidate Disease Mechanisms
por: Tam, Hoi Ki Joshua, et al.
Publicado: (2022)

IL-26 Is Overexpressed in Rheumatoid Arthritis and Induces Proinflammatory Cytokine Production and Th17 Cell Generation
por: Corvaisier, Murielle, et al.
Publicado: (2012)

Consequences of bariatric surgery on outcomes in rheumatic diseases
por: Lespessailles, Eric, et al.
Publicado: (2019)

Correction: IL-26 Is Overexpressed in Rheumatoid Arthritis and Induces Proinflammatory Cytokine Production and Th17 Cell Generation
por: Corvaisier, Murielle, et al.
Publicado: (2012)

Wearable transcutaneous electrical nerve stimulation (actiTENS®) is effective and safe for the treatment of knee osteoarthritis pain: a randomized controlled trial versus weak opioids
por: Maheu, Emmanuel, et al.
Publicado: (2022)

Blocking IL-17: A Promising Strategy in the Treatment of Systemic Rheumatic Diseases
por: Rafael-Vidal, Carlos, et al.
Publicado: (2020)

Loss of CD103+ DCs and Mucosal IL-17+ and IL-22+ Lymphocytes is Associated with Mucosal Damage in SIV Infection
por: Klatt, Nichole R., et al.
Publicado: (2012)

Prevention of bone mineral density loss in patients with rheumatoid arthritis treated with anti-TNFα therapy
por: Marotte, Hubert, et al.
Publicado: (2008)

The Role of IL-1β in the Bone Loss during Rheumatic Diseases
por: Ruscitti, Piero, et al.
Publicado: (2015)

Direct and Indirect Relationships Between Physical Activity, Fitness Level, Kinesiophobia, and Health-Related Quality of Life in Patients with Rheumatic and Musculoskeletal Diseases: A Network Analysis
por: Courbalay, Anne, et al.
Publicado: (2021)

Factors influencing bone loss in anorexia nervosa: assessment and therapeutic options
por: Legroux, Isabelle, et al.
Publicado: (2019)

IL-33 in Rheumatic Diseases
por: Dong, Yuanji, et al.
Publicado: (2021)

A 1-year case-control study in patients with rheumatoid arthritis indicates prevention of loss of bone mineral density in both responders and nonresponders to infliximab
por: Marotte, Hubert, et al.
Publicado: (2007)

NAMPT/Visfatin expression by inflammatory monocytes mediates arthritis pathogenesis by promoting IL-17–producing T cells
por: Présumey, Jessy, et al.
Publicado: (2012)

The Role of IL-33 in Rheumatic Diseases
por: Duan, Lihua, et al.
Publicado: (2013)

Implications of COVID-19 for the management of patients with inflammatory rheumatic diseases
por: Richez, Christophe, et al.
Publicado: (2020)

Characteristic Pattern of IL-17RA, IL-17RB, and IL-17RC in Monocytes/Macrophages and Mast Cells From Patients With Bullous Pemphigoid
por: Nesmond, Stéphane, et al.
Publicado: (2019)

Involvement of IL17A, IL17F and IL23R Polymorphisms in Colorectal Cancer Therapy
por: Omrane, Inés, et al.
Publicado: (2015)

Could Biomarkers of Bone, Cartilage or Synovium Turnover Be Used for Relapse Prediction in Rheumatoid Arthritis Patients?
por: Dénarié, Delphine, et al.
Publicado: (2014)

Serum concentrations of IL-17A, IL-17B, IL-17E and IL-17F in patients with systemic sclerosis
por: Robak, Ewa, et al.
Publicado: (2019)

Mucocutaneous candidiasis: the IL-17 pathway and implications for targeted immunotherapy
por: Huppler, Anna R, et al.
Publicado: (2012)

IL-17A in Psoriasis and Beyond: Cardiovascular and Metabolic Implications
por: von Stebut, Esther, et al.
Publicado: (2020)

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study
por: Avouac, Jérôme, et al.
Publicado: (2021)

Social implications of rheumatic diseases
por: Kłak, Anna, et al.
Publicado: (2016)

Current data on IL-17 and Th17 cells and implications for graft versus host disease
por: Normanton, Marília, et al.
Publicado: (2013)

IL-6 Amplifies TLR Mediated Cytokine and Chemokine Production: Implications for the Pathogenesis of Rheumatic Inflammatory Diseases
por: Caiello, Ivan, et al.
Publicado: (2014)

Rare incidence of methotrexate-specific lesions in liver biopsy of patients with arthritis and elevated liver enzymes
por: Quintin, Emilie, et al.
Publicado: (2010)

IL-17-induced dimerization of IL-17RA drives the formation of the IL-17 signalosome to potentiate signaling
por: Goepfert, Arnaud, et al.
Publicado: (2022)

IL-17/Th17 Pathway Is Activated in Acne Lesions
por: Kelhälä, Hanna-Leena, et al.
Publicado: (2014)

New biologic (Ab-IPL-IL-17) for IL-17-mediated diseases: identification of the bioactive sequence (nIL-17) for IL-17A/F function
por: Saviano, Anella, et al.
Publicado: (2023)

Vertebroplasty for osteoporotic vertebral fracture
por: Roux, Christian, et al.
Publicado: (2021)

IL-17A, IL-17RC polymorphisms and IL17 plasma levels in Tunisian patients with rheumatoid arthritis
por: Dhaouadi, Tarak, et al.
Publicado: (2018)

Neutralization of IL-17 ameliorates uveitis but damages photoreceptors in a murine model of spondyloarthritis
por: Kezic, Jelena M, et al.
Publicado: (2012)

Tissue Damage in Radiation-Induced Oral Mucositis Is Mitigated by IL-17 Receptor Signaling
por: Saul-McBeth, Jessica, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8v3qi6eg187oslkor1ifpssi5l